12 July 2022
At the meeting of 7 June 2022 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
hiatus hernia | 60/2022 | 61/2022 |
otitis media | 62/2022 | 63/2022 |
somatic symptom disorder | 64/2022 | 65/2022 |
sick sinus syndrome | 66/2022 | 67/2022 |
sleep apnoea | 68/2022 | 69/2022 |
dermatomyositis | 70/2022 | 71/2022 |
erectile dysfunction | 72/2022 | 73/2022 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
Guillain-Barre syndrome | 74/2022 | 75/2022 |
osteoarthritis | 76/2022 | 77/2022 |
The above SOPs take effect from 25 July 2022.
Summary of Changes
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
restless legs syndrome | Intention to remove one or more factors | October 2022 |
allergic rhinitis | Intention to remove one or more factors | October 2022 |
Completed Investigations
The above determinations conclude the previously advertised investigations into:
- hiatus hernia
- otitis media
- somatic symptom disorder
- sick sinus syndrome
- sleep apnoea
- dermatomyositis
- erectile dysfunction
- Guillain-Barre syndrome (focussed review - coronavirus disease 2019 (COVID-19) vaccines)
- osteoarthritis (focussed review - repetitive activities of the upper limb)
New Investigation
Decided to advertise the following investigation:
- gingivitis (focussed review - definition of 'combined oral contraceptive pill as specified')
The above investigation notice appears in the Government Notices Gazette of 4 July 2022.